CLIENT CODE : C000022844
Cert. No. MC-2015
CLIENT'S NAME AND ADDRESS :
SRL PSC - PARK ROAD (WALK-IN) SRL LIMITED
SHOP NO.-B-12, REGENCY PLAZA, PARK ROAD, OPP. CIVIL HOSPITAL, SRL,REFERENCE LAB, GP-26, MARUTI INDUSTRIAL ESTATE,UDYOG
VIHAR,SECTOR-18,
LUCKNOW 226001 GURGAON, 122015
UTTAR PRADESH INDIA HARYANA, INDIA
0522-4109754 7607001702 Tel : 1800-222-000, 1800-102-8282, Fax : CIN -
U74899PB1995PLC045956
Email :
[email protected]PATIENT NAME : SHAFQUAT NAZAR SABRI PATIENT ID : SHAFM03068124
ACCESSION NO : 0024TF000619 AGE : 39 Years SEX : Male DATE OF BIRTH :
DRAWN : 03/06/2020 00:00 RECEIVED : 03/06/2020 17:27 REPORTED : 05/06/2020 12:30
REFERRING DOCTOR : DR. SAMEER PARATE CLIENT PATIENT ID :
CLINICAL INFORMATION :
ICMR Registration No: SRLRL001
0916200000090
Test Report Status Final Results Biological Reference Interval Units
MOLECULAR BIOLOGY
SARS COV -2 REAL TIME PCR
SARS-COV-2 RNA NOT DETECTED NOT DETECTED
Interpretation(s)
SARS COV -2 REAL TIME PCR-
SARS-CoV-2, formerly known as 2019-nCoV, is the causative agent of the coronavirus disease 2019 (COVID-19). Main symptoms of the disease include fever, cough and
shortness of breath. The virus is spread via person-to-person contact through respiratory droplets produced when a person coughs or sneezes. The SARS-CoV-2 RNA is
generally detectable in nasopharyngeal/oropharyngeal swabs during the acute phase of infection. Positive results are indicative of active infection. Real Time PCR assay
targets E and RdRp/S gene and can be used for diagnosis of SARS-CoV-2 virus infection which contributes to severe upper respiratory distress, complications
Methodology: Real Time PCR
Interpretation:
Detected result is considered a positive test result for COVID-19. This indicates that RNA from SARS-CoV-2 was detected, and the patient is considered infected with the virus
and presumed to be contagious.
Not Detected test result for this test means that SARS-CoV-2 RNA was not present in the specimen above the limit of detection.
Limitations:
• Negative results do not preclude COVID-19 and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical
observations, patient history, and epidemiological information.
• Positive results but do not rule out bacterial infection or co-infection with other viruses.
• Optimum specimen types and timing for peak viral levels during infections caused by 2019-nCoV have not been determined. Collection of multiple specimens (types and
time points) from the same patient may be necessary to detect the virus.
• If the virus mutates in the rRT-PCR target region, 2019-nCoV may not be detected or may be detected less predictably. Inhibitors or other types of interference may
produce a false negative result.
• The performance of this test has not been established for monitoring treatment of 2019-nCoV infection.
Note: Test is performed using ICMR approved Kit.
References:
1. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases. Interim guidance. World Health Organization.
2. Druce et al. JCM. 2011
3. N. Engl. J. Med. 2020, 382, 929–936
**End Of Report**
Please visit www.srlworld.com for related Test Information for this accession
Dr. Rashmi Talwar, PhD Dr. Yoginder Pal Singh, Ph.D Dr. Anurag Bansal
Section Head- Genetics Molecular Biologist LAB DIRECTOR
Page 1 Of 1
